FeesSafety
Pluang+

Legence sets Q3 2026 earnings release for Nov 12 with a webcast and call.

Company Fundamentals
29 Oct 2026, 14:00 WIB
GlobeNewsWire
View Source
Neutral
Legence sets Q3 2026 earnings release for Nov 12 with a webcast and call.

Legence Corp. announced it will release its third quarter 2026 earnings on November 12, 2026, before the market opens. The company will hold a webcast and conference call at 10:00 am EST the same day to discuss the results and business operations. Investors can access the live call and slide presentation on Legence's website, with a replay available until December 12, 2026. This event provides insight into Legence's ongoing performance in engineering and consulting services for critical building systems.

Legence Corp.'s upcoming third quarter 2026 earnings release is noted here with Pluang's Industrials sector market data for context. For readers following Industrials, 77 of 135 priced US stocks rose while 54 fell. Notable movers include HONA at USD 172.52 with a -2.55% change, CP at USD 87.23 with -2.46%, and HWM at USD 199.99 with +2.39% and 100% buy order activity on Pluang, as of Oct 29, 2026 17:11 WIB.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App